Maha Saad
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 9
- Advanced biosensing and bioanalysis techniques 5
-
- Nanoparticle-Based Drug Delivery 6
- Co-authors
- Tamara Minko (10 shared papers)Olga B. Garbuzenko (5 shared papers)Jayant Khandare (6 shared papers)Vitaly P. Pozharov (4 shared papers)Pooja Chandna (3 shared papers)Refika I. Pakunlu (3 shared papers)Viatcheslav A. Soldatenkov (3 shared papers)Alexandre A. Vetcher (3 shared papers)
- Journals
- Journal of Controlled Release (2 papers)Palliative & Supportive Care (2 papers)Molecular Pharmaceutics (1 paper)Clinical Cancer Research (1 paper)JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (1 paper)
- Partner nations
- United StatesMexicoEgypt
In The Last Decade
Maha Saad
27 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Biomaterials 578
- Pharmaceutical Science 102
- Molecular Biology 748
- Oncology 193
- Biomedical Engineering 310
Countries citing papers authored by Maha Saad
This map shows the geographic impact of Maha Saad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Saad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Saad more than expected).
Fields of papers citing papers by Maha Saad
This network shows the impact of papers produced by Maha Saad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Saad. The network helps show where Maha Saad may publish in the future.
Co-authors
The 25 scholars most cited alongside Maha Saad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 309 | |
| 2 | 2008 | 179 | |
| 3 | 2010 | 152 | |
| 4 | 2008 | 132 | |
| 5 | 2006 | 102 | |
| 6 | 2005 | 73 | |
| 7 | 2006 | 69 | |
| 8 | 2007 | 63 | |
| 9 | 2007 | 56 | |
| 10 | 2008 | 47 | |
| 11 | 2010 | 36 | |
| 12 | 2017 | 32 | |
| 13 | 2019 | 26 | |
| 14 | 2012 | 13 | |
| 15 | 2013 | 11 | |
| 16 | 2019 | 9 | |
| 17 | 2010 | 8 | |
| 18 | 2013 | 5 | |
| 19 | 2013 | 4 | |
| 20 | 2023 | 4 |
About Maha Saad
Maha Saad is a scholar working on Molecular Biology, Biomaterials, Surgery, Biomedical Engineering and Pharmacology, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Nanoparticle-Based Drug Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), Nanoplatforms for cancer theranostics (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Intensive Care Unit Cognitive Disorders (2 papers), Electroconvulsive Therapy Studies (2 papers) and Dendrimers and Hyperbranched Polymers (2 papers). The work is most often cited by research in Biomaterials (578 citations), Pharmaceutical Science (102 citations), Molecular Biology (748 citations), Oncology (193 citations) and Biomedical Engineering (310 citations). Maha Saad has collaborated with scholars based in United States, Mexico and Egypt. Frequent co-authors include Tamara Minko, Olga B. Garbuzenko, Jayant Khandare, Vitaly P. Pozharov, Pooja Chandna, Refika I. Pakunlu, Viatcheslav A. Soldatenkov, Alexandre A. Vetcher, Kenneth R. Reuhl and Gediminas Mainelis. Their work appears in journals such as Journal of Controlled Release, Palliative & Supportive Care, Molecular Pharmaceutics, Clinical Cancer Research and JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.